Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Levetiracetam in Schizophrenia
NCT02647437Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2013
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of levetiracetam in schizophrenia (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Resting-state Neuronal Response at 2 weeks. Started Jun 2013; status: completed.
02
Drugs
levetiracetam
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02647437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647437.